SEC Form 4 · accession 0001144204-15-050715
Arch Therapeutics, Inc. · ARTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Avtar S Dhillon
Director
Period of report
Aug 18, 2015
Accepted (ET)
Aug 19, 2015 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001537561
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.28 | Aug 18, 2015 | A | 355,000 | A | — | Aug 17, 2025 | Common Stock | 355,000 | 355,000 | D |
Explanation of responses
- F1Of the Shares subject to this Option, 1/12 shall vest in equal monthly installments on the first day of the month following August 18, 2015 and on each monthly anniversary thereafter.